STAT3-induced S1PR1 expression is crucial for persistent STAT3 activation in tumors

Heehyoung Lee(City of Hope), Hua Yu(City Of Hope National Medical Center), David Horné(City of Hope), Richard Jove(University of South Florida), George Somlo(City Of Hope National Medical Center), Stephen J. Forman(City Of Hope National Medical Center), Maciej Kujawski(City Of Hope National Medical Center), Andreas Herrmann(DWI – Leibniz Institute for Interactive Materials), Chunmei Yang(City of Hope), Jiehui Deng(NYU Langone Health), Yong Liu(Chinese Academy of Agricultural Sciences), Marcin Kortylewski(City Of Hope National Medical Center)
Nature Medicine
November 21, 2010
10.1038/nm.2250
Cited by 395

Related Papers

Regression of Glioblastoma after Chimeric Antigen Receptor T-Cell Therapy
|New England Journal of Medicine|2016|1.8k
Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: a Southwest Oncology Group/Eastern Cooperative Oncology Group study
|Blood|2000|1.6k
Safety and activity of blinatumomab for adult patients with relapsed or refractory B-precursor acute lymphoblastic leukaemia: a multicentre, single-arm, phase 2 study
|The Lancet Oncology|2014|1.3k
Bioactivity and Safety of IL13Rα2-Redirected Chimeric Antigen Receptor CD8+ T Cells in Patients with Recurrent Glioblastoma
|Clinical Cancer Research|2015|754
Adoptive immunotherapy for indolent non-Hodgkin lymphoma and mantle cell lymphoma using genetically modified autologous CD20-specific T cells
|Blood|2008|719